In animal models, MOTS-c significantly reduced bone loss in ovariectomized mice (mimicking menopause) through dual mechanisms: promoting osteoblast differentiation and inhibiting osteoclast formation
The products are not medicines or drugs and they have not been approved by the fda to prevent, treat, diagnose, mitigate, or cure any disease, ailment or medical condition
In a meta-analysis of 17 randomized trials comparing GLP-1RA (exenatide, liraglutide, albiglutide, taspoglutide, lixisenatide) with placebo or an active comparator in patients with T2DM, patients treated with GLP-1RA experienced more nausea, diarrhea, and weight loss when compared to placebo or patients on active comparator (32)
BPC-157 also appears on WADA's prohibited list
And yeah, that's it
These sensations are usually brief and may occur if the drip rate is too rapid